Corporate Governance

Corporate Governance

Press Releases View all

January 22, 2020

BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer

January 14, 2020

BioLineRx Receives Orphan Drug Designation for Motixafortide (BL-8040) for the Treatment of Pancreatic Cancer in Europe

January 8, 2020

BioLineRx to Present at the 2020 Biotech Showcase

Upcoming Events View all